157 related articles for article (PubMed ID: 29190899)
1. Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice.
Hu ZQ; Luo JF; Yu XJ; Zhu JN; Huang L; Yang J; Fu YH; Li T; Xue YM; Feng YQ; Shan ZX
Oncotarget; 2017 Nov; 8(54):92079-92089. PubMed ID: 29190899
[TBL] [Abstract][Full Text] [Related]
2. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
4. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
Zhu WS; Tang CM; Xiao Z; Zhu JN; Lin QX; Fu YH; Hu ZQ; Zhang Z; Yang M; Zheng XL; Wu SL; Shan ZX
Oncotarget; 2016 Nov; 7(48):78331-78342. PubMed ID: 27823969
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
8. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
9. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
10. [Overexpression of miR-130a-3p attenuates cardiomyocyte hypertrophy].
Wang X; Qu J; Li D; Li J; Wu W; Liu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Apr; 37(2):340-348. PubMed ID: 32329288
[TBL] [Abstract][Full Text] [Related]
11. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150.
Zhu XH; Yuan YX; Rao SL; Wang P
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3653-60. PubMed ID: 27649667
[TBL] [Abstract][Full Text] [Related]
13. MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.
Cao X; Zhang Z; Wang Y; Shan W; Wang R; Mao S; Ding S; Pang C; Li B; Zhou J; Guo X; Guo N; Li C; Liang J; Ma W; Liu Y; Zhao L
Front Pharmacol; 2021; 12():680349. PubMed ID: 34248630
[TBL] [Abstract][Full Text] [Related]
14. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase D participates in cardiomyocyte hypertrophy by regulating extracellular signal-regulated and myocyte enhancer factor 2D.
Yuan H; Xiang Q; Yang L; Geng J
Rev Port Cardiol (Engl Ed); 2021 Mar; 40(3):191-200. PubMed ID: 33334620
[TBL] [Abstract][Full Text] [Related]
17. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Yu L; She T; Li M; Shi C; Han L; Cheng M
Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
[TBL] [Abstract][Full Text] [Related]
19. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
Wu Y; Wang YQ; Wang BX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.
Zhang K; Zhuo H; Guo J; Wang W; Dai R
Int Heart J; 2024; 65(1):119-127. PubMed ID: 38296564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
